登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Angiotensinogen】

Angiotensinogen信息

英文名称:Angiotensinogen
中文名称:血管紧张素
靶点别称:Angiotensinogen,Angiotensin I,Ang III,Angiotensin 3-8,Serpin A8,Angiotensin 2-8,Angiotensin 1-8,Angiotensin IV,Ang II,Angiotensin 1-10,Ang IV,Angiotensin II,Des-Asp[1]-angiotensin II,Alpha-1 Antiproteinase, Antitrypsin,ANHU,Fetal-Liver Predominant Transporter 1,SERPINA8,Pre-Angiotensinogen,Serine (Or Cysteine) Proteinase Inhibitor,HFLT1,Serpin Peptidase Inhibitor, Clade A, Member 8,Ang I,Angiotensin III
上市药物数量:0
临床药物数量:7
最高研发阶段:临床三期

Angiotensinogen产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
ANN-H5243
Human
Human Angiotensinogen Protein, His Tag (MALS verified)
ACRO质量管理体系
 
评论(0)
 

Angiotensinogen分子别名

ANHU, SERPINA8, hFLT1

Angiotensinogen分子背景

The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure, body fluid and electrolyte homeostasis, and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.

Angiotensinogen临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
N-0877 N0877; N-0877 临床三期 Eurofarma Laboratorios Sa 原发性高血压 详情
Zilebesiran ALN-AGT01; ALN-AGT-01; ALN-AGT; RG-6615 临床二期 Alnylam Pharmaceuticals Inc 高血压, 先兆子痫, 心脏和血管疾病 详情
IONIS-AGT-LRx ISISAGTLRx; IONISAGTLRx; ISIS-757456 临床二期 Ionis Pharmaceuticals Inc 心脏衰竭, 高血压 详情
Tonlamarsen sodium ION-904; AGT-2.5-LRx 临床二期 Ionis Pharmaceuticals Inc 高血压, 心脏和血管疾病 详情
SGB-3908 IBI-3016; IBI3016; SGB-3908 临床一期 美国圣因生物公司 高血压, 代谢病, 原发性高血压 详情
BW-00163 BW-00163; BW00163 临床一期 上海舶望制药有限公司 高血压 详情

消息提示

请输入您的联系方式,再点击提交!

确定